Advertisement
Advertisement
ILMN
Illumina Inc
141.88
USDSponsored
+3.17
+2.29%
May 08, 16:00 UTC -4
Closed
After-Market
140.47
-1.41
-0.99%
ILMN Earnings Reports
Positive Surprise Ratio
ILMN beat 33 of 41 last estimates.
80%
Next Report
Date of Next Report
Jul 29, 2026
Estimate for Q2 26 (Revenue/ EPS)
$1.14B
/$1.25
Implied change from Q1 26 (Revenue/ EPS)
+4.90%
/+9.65%
Implied change from Q2 25 (Revenue/ EPS)
+8.07%
/+5.04%
Illumina Inc earnings per share and revenue
On Apr 30, 2026, ILMN reported earnings of 1.14 USD per share (EPS) for Q1 26, beating the estimate of 1.07 USD, resulting in a 6.94% surprise. Revenue reached 1.09 billion, compared to an expected 1.09 billion, with a -0.34% difference. The market reacted with a +7.13% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 18 analysts forecast an EPS of 1.25 USD, with revenue projected to reach 1.14 billion USD, implying an increase of 9.65% EPS, and increase of 4.90% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Gilead Sciences Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.95
Actual
$2.02
Surprise
+3.97%
Palvella Therapeutics, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.95
Actual
-$1.20
Surprise
-26.21%
ANI Pharmaceuticals, Inc.
Report Date
May 08, 2026 For Q1 26
Estimate
$1.33
Actual
$2.04
Surprise
+54.04%
Harmony Biosciences Holdings, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.72
Actual
$0.55
Surprise
-24.16%
Lexicon Pharmaceuticals, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.03
Actual
$0.00
Surprise
+100.00%
Zura Bio Limited Class A Ordinary Shares
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.17
Actual
-$0.22
Surprise
-23.94%
Absci Corporation Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.21
Actual
-$0.19
Surprise
+11.30%
ALX Oncology Holdings Inc. Common Stock
Report Date
May 08, 2026 For Q1 26
Estimate
-$0.22
Actual
-$0.17
Surprise
+24.24%
Codexis, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.13
Actual
-$0.10
Surprise
+28.26%
Entera Bio Ltd. Ordinary Shares
Report Date
May 08, 2026 For Q1 26
Estimate
-$0.15
Actual
-$0.07
Surprise
+54.25%
FAQ
What were Illumina Inc's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Illumina Inc reported EPS of $1.14, beating estimates by 6.94%, and revenue of $1.09B, -0.34% below expectations.
How did the market react to Illumina Inc's Q1 2026 earnings?
The stock price moved up 7.13%, changed from $126.74 before the earnings release to $135.78 the day after.
When is Illumina Inc expected to report next?
The next earning report is scheduled for Jul 29, 2026.
What are the forecasts for Illumina Inc's next earnings report?
Based on 18
analysts, Illumina Inc is expected to report EPS of $1.25 and revenue of $1.14B for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement